Synergistic Effects between Q192R Polymorphism of Paraoxonase 1 Gene and Some Conventional Risk Factors in Premature Coronary Artery Disease

Archives of Medical Research

Volumn 38, Issue 5, 2007, Pages 545-550

  Balcerzyk, Anna ^a   Zak, Iwona ^a   Krauze, Jolanta ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Conventional risk factor; Coronary artery disease; Paraoxonase 1; Polymorphism

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; ALLELES; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 34249867184     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.03.004     Document Type: Article

References (21)

1. Carpenter K.L., Taylor S.E., Van der Veen C., Williamson B.K., Ballantine J.A., and Mitchinson M.J. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta 1256 (1995) 141-150
2. Vasankari T., Ahotupa M., Toikka J., Mikkola J., Irjala K., Pasanen P., et al. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 155 (2001) 403-412
3. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., and Hegele R.A. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7 (1996) 69-76
4. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101 (1998) 1581-1590
5. Alpert J.S., and Thygesen K. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21 (2000) 1502-1513
6. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative centrifuge. Clin Chem 18 (1972) 499-502
7. Ombres D., Pannitteri G., Montali A., Candeloro A., Seccareccia F., Campagna F., et al. The Gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler Thromb Vasc Biol 18 (1998) 1611-1616
8. Khoury M.J., and Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!. Am J Epidemiol 144 (1996) 207-213
9. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss 97 (2004) 1019-1030
10. Mackness B., Mackness M.I., Arrol S., Turkie W., and Durrington P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423 (1998) 57-60
11. Agachan B., Yilmaz H., Ergen H.A., Karaali Z.E., and Isbir T. Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus. Physiol Res 54 (2005) 287-293
12. Kuremoto K., Watanabe Y., Ohmura H., Shimada K., Mokuno H., and Daida H. R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J Atheroscler Thromb 10 (2003) 85-92
13. Aviram M., Billecke S., Sorenson R., Bisgaier C., Newton R., Rosenblat M., et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities. Arterioscler Thromb Vasc Biol 18 (1998) 1617-1624
14. Lacinski M., Skorupski W., Cieslinski A., Sokolowska J., Trzeciak W.H., and Jakubowski H. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans. Cell Mol Biol 50 (2004) 885-893
15. Gaidukov L., Rosenblat M., Aviram M., and Tawfik D.S. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux. J Lipid Res 47 (2006) 2492-2502
16. Sanghera D.K., Saha N., Aston C.E., and Kamboh M.I. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 17 (1997) 1067-1073
17. Lawlor D.A., Day I.N., Gaunt T.R., Hinks L.J., Briggs P.J., Kiessling M., et al. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis. BMC Genet 23 5 (2004) 17
18. Leus F.R., Wittekoek M.E., Prins J., Kastelein J.J., and Voorbij H.A. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 149 (2000) 371-377
19. Dessi M., Gnasso A., Motti C., Pujia A., Irace C., Casciani S., et al. Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population. Coron Artery Dis 10 (1999) 595-599
20. James R.W., Leviev I., and Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 101 (2000) 2252-2257
21. Senti M., Aubo C., and Tomas M. Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene. Metabolism 49 (2000) 557-559